KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio (2018 - 2025)

Historic Interest Coverage Ratio for Vertex Pharmaceuticals (VRTX) over the last 10 years, with Q3 2025 value amounting to 359.45.

  • Vertex Pharmaceuticals' Interest Coverage Ratio rose 14150.4% to 359.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 311.98, marking a year-over-year increase of 453054.73%. This contributed to the annual value of 7.61 for FY2024, which is 10875.91% down from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 359.45 for Q3 2025, which was up 14150.4% from 311.11 recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Interest Coverage Ratio ranged from a high of 366.43 in Q4 2024 and a low of 355.02 during Q2 2024
  • For the 3-year period, Vertex Pharmaceuticals' Interest Coverage Ratio averaged around 143.05, with its median value being 129.2 (2024).
  • The largest annual percentage gain for Vertex Pharmaceuticals' Interest Coverage Ratio in the last 5 years was 29293.3% (2024), contrasted with its biggest fall of 48739.54% (2024).
  • Quarter analysis of 3 years shows Vertex Pharmaceuticals' Interest Coverage Ratio stood at 93.25 in 2023, then surged by 292.93% to 366.43 in 2024, then dropped by 1.9% to 359.45 in 2025.
  • Its Interest Coverage Ratio was 359.45 in Q3 2025, compared to 311.11 in Q2 2025 and 210.03 in Q1 2025.